Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1447]
News [2210]
Articles [39]
Editorials [5]
Conferences [150]
elearning [0]
(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(5/6) ASCO 2017: ASCO highlights in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(5/6) ASCO 2017: ASCO highlights in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(6/6) ASCO 2017: Round up of expert discussion on the latest in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(6/6) ASCO 2017: Round up of expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
ASCO 2017: Following the practice changing results from STAMPEDE
Dr Neal Shore and Prof Nicholas James
ASCO 2017: Following the practice changing results from STAMPEDE ( Dr Neal Shore and Prof Nicholas James )
5 Jun 2017
Immunotherapy may slow the growth of malignant pleural mesothelioma
Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France
Immunotherapy may slow the growth of malignant pleural mesothelioma ( Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France )
5 Jun 2017
Immunotherapy for mesothelioma could be on the horizon
Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France
Immunotherapy for mesothelioma could be on the horizon ( Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France )
5 Jun 2017
CAR T-cell therapy can be used to send multiple myeloma into lasting remission
Dr Wanhong Zhao - Xi’an Jiaotong University Hospital, China
CAR T-cell therapy can be used to send multiple myeloma into lasting remission ( Dr Wanhong Zhao - Xi’an Jiaotong University Hospital, China )
5 Jun 2017
Adding a second HER2 targeted medicine may lower chance of invasive breast...
Dr Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany
Adding a second HER2 targeted medicine may lower chance of invasive breast cancer ( Dr Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany )
5 Jun 2017
Low testosterone after testicular cancer could be linked to chronic health...
Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine...
Low testosterone after testicular cancer could be linked to chronic health problems ( Dr Mohammad Issam Abu Zaid - Indiana University School of Medicine, Indianapolis, USA )
2 Jun 2017
Hallmarks of cancer cell development
Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne...
Hallmarks of cancer cell development ( Dr Douglas Hanahan - Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland )
27 Apr 2017
75 years of Tata Memorial Centre
Dr Rajendra Badwe - Tata Memorial Centre, Mumbai, India
75 years of Tata Memorial Centre ( Dr Rajendra Badwe - Tata Memorial Centre, Mumbai, India )
29 Mar 2017
Peer learning in the National Cancer Grid
Dr C. S. Pramesh - Tata Memorial Centre, Mumbai, India
Peer learning in the National Cancer Grid ( Dr C. S. Pramesh - Tata Memorial Centre, Mumbai, India )
29 Mar 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation